TG Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TGTX Nasdaq 2830 www.tgtherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for TG Therapeutics, Inc.

TG Therapeutics (NasdaqCM:TGTX) Stock Rises 13% In Last Month - Jun 6th, 2025 11:36 am
TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Jun 6th, 2025 5:30 am
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference - Jun 2nd, 2025 6:00 am
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - May 30th, 2025 5:30 am
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - May 27th, 2025 5:30 am
Exploring 3 High Growth Tech Stocks In The US Market - May 21st, 2025 5:41 am
TG Therapeutics, Inc. (TGTX): Among the Best Cancer Stocks to Invest in for Long-Term Gain - May 9th, 2025 8:28 am
TG Therapeutics First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - May 6th, 2025 4:20 am
TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Strong BRIUMVI Sales and Increased ... - May 6th, 2025 1:03 am
Why TG Therapeutics Stock Was Tumbling Today - May 5th, 2025 1:37 pm
TG Therapeutics (TGTX) Lags Q1 Earnings Estimates - May 5th, 2025 6:10 am
TG Therapeutics: Q1 Earnings Snapshot - May 5th, 2025 5:08 am
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance - May 5th, 2025 5:00 am
TG Therapeutics (TGTX) to Report Q1 Results: Wall Street Expects Earnings Growth - Apr 30th, 2025 8:01 am
TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update - Apr 30th, 2025 5:30 am
TG Therapeutics (NasdaqCM:TGTX) Sees Profitable Turn With Strong Quarterly Earnings - Apr 28th, 2025 12:00 pm
Exploring US High Growth Tech Stocks - Apr 17th, 2025 5:38 am
TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why - Apr 10th, 2025 9:50 am
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting - Apr 10th, 2025 5:30 am
TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals - Apr 7th, 2025 5:30 am